Flavonoid compound as well as preparation method and application thereof

By combining freeze-drying and ultrasonic extraction methods, the effective antibacterial ingredient in Jinhu cactus is clarified as flavonoid compounds, which solves the problem of poor antibacterial effect of existing cactus extracts, and improves the biological activity and application value of the extract. Provides a highly efficient and stable natural antibacterial active substance.

CN119019351AActive Publication Date: 2024-11-26SHANGHAI CHEERMORE IND DEV CO LTD

Patent Information

Application Number
CN202411122598.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-15
Publication Date
2024-11-26
Estimated Expiration
2044-08-15

AI Technical Summary

Technical Problem

The antibacterial effect of existing cactus extracts is not good, mainly due to the lack of clear effective ingredients in the extract that plays an antibacterial effect and the damage to the antibacterial active ingredients during the extraction process.

Method used

The method of combining freeze-drying and ultrasonic extraction was used to extract the golden amber cactus, and the organic membrane was filtration, combined with gradient elution and concentration under reduced pressure to obtain high-purity flavonoid compounds.

Benefits of technology

Improve the biological activity and application value of the extract, ensure the consistency and repeatability of the extract, provide an efficient and stable natural antibacterial active substance, reduce the viscosity of the extraction system and the difficulty of subsequent purification, and avoid Destruction of flavonoids.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119019351A_ABST
    Figure CN119019351A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of natural bacteriostatic active substances, in particular to a flavonoid compound as well as a preparation method and application thereof. The preparation method of the flavonoid compound comprises the following steps: removing thorns of cactus dehydroandrographolide, freeze-drying, and grinding to obtain cactus dehydroandrographolide powder; sequentially carrying out ultrasonic alcohol extraction and organic membrane filtration on the cactus dehydroandrographolide powder to obtain an extract mother solution; and separating and purifying the mother liquor to obtain the flavonoid compound. The invention clarifies the structure of the antibacterial active ingredient in the cactus dehydroandrographolide succinate extract, and correspondingly provides a preparation method of the flavonoid compound, so that the biological activity and application value of the extract are improved, the consistency and repeatability of the extract are ensured, and the application prospect is wide. Meanwhile, an efficient and stable natural active substance is provided for the antibacterial field.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of natural antibacterial active substances, in particular to flavonoid compounds and preparation methods and applications thereof. Background Art

[0002] Golden Bark (Echinocactus grusonii) is a perennial succulent plant of the genus Echinocactus in the Cactaceae family. Its chemical composition and properties have attracted extensive research and commercial interest. Golden Bark is rich in various phytochemicals, including polysaccharides, phenolics, pigments, triterpenes, and saponins. These components endow Golden Bark with a variety of biological activities, such as anti-inflammatory, antioxidant, antibacterial, anticancer, anti-atherosclerotic, anti-diabetic, neuroprotective and intestinal protective properties. Therefore, Golden Bark has potential application value in the fields of food, health products and medicine.

[0003] At present, the extraction methods of cactus polysaccharides mainly include hot water method, acid method, enzyme method, ultrasonic method, microwave-assisted method and microbial method. Although the active ingredients in golden barrel cactus have multiple biological activities, existing studies have shown that the extracts obtained by traditional extraction methods have average antibacterial effects, which seriously limits its application in the antibacterial field. Summary of the invention

[0004] In order to solve or partially solve the problems existing in the related art, the present invention provides a flavonoid compound and a preparation method and application thereof.

[0005] The present invention provides a method for preparing a flavonoid compound, comprising:

[0006] The thorns of the golden ebony cactus are removed, freeze-dried, and then ground to obtain golden ebony cactus powder;

[0007] The powder of golden equisetum cactus is subjected to ultrasonic alcohol extraction and organic membrane filtration in sequence to obtain an extract mother liquor;

[0008] The mother liquor is separated and purified to obtain the flavonoid compound represented by formula I:

[0009]

[0010] Furthermore, the freeze-drying temperature is -40°C to -20°C, and the time is 42h to 72h.

[0011] Furthermore, the temperature of the ultrasonic alcohol extraction is 45°C to 55°C, and the time is 1.5h to 3.0h.

[0012] Furthermore, the ultrasonic alcohol extraction extract is an ethanol solution with a concentration of 80%, and the solid-liquid ratio of the golden ebony cactus powder to the ethanol solution is 1g: (25-45)mL.

[0013] Furthermore, the pore size of the organic membrane is 0.45 μm.

[0014] Furthermore, the separation and purification is specifically:

[0015] The mother liquor is filtered; silica gel is added to the filtrate, and then it is concentrated under reduced pressure to obtain a stationary phase; the stationary phase is gradient eluted with dichloromethane and methanol as developing solvents, and the elution phase with a gradient of dichloromethane: methanol = 15:1 to dichloromethane: methanol = 5:1 is collected to obtain a crude product; the crude product is concentrated under reduced pressure to obtain a flavonoid compound shown in formula I.

[0016] Furthermore, the temperature of the reduced pressure concentration is 45°C to 55°C.

[0017] Furthermore, the mass ratio of the mother liquor to the silica gel is (10-18):1; the gradient elution range of the developing agent is dichloromethane:methanol=100:1 to dichloromethane:methanol=1:1.

[0018] The present invention also provides a flavonoid compound, the structure of which is shown in Formula I:

[0019]

[0020] The present invention also provides an application of the flavonoid compound in an antibacterial product, wherein the antibacterial product comprises one or more of cosmetics, medicines, health products and food additives.

[0021] The flavonoid compounds and preparation methods provided by the present invention may have the following beneficial effects:

[0022] 1) It is clarified that the structure of the antibacterial active ingredient in the golden equisetum cactus extract is a flavonoid compound as described in formula I, and a corresponding preparation method of the flavonoid compound is provided, thereby improving the biological activity and application value of the extract, ensuring the consistency and repeatability of the extract, and providing a highly efficient and stable natural active substance for the antibacterial field.

[0023] 2) The preparation method first performs freeze drying before ultrasonic extraction on the thornless golden barrel cactus, which reduces the viscosity of the extraction system, makes the extraction process more uniform, and improves the consistency and repeatability of the extraction; in addition, the freeze drying process is carried out at a low temperature, which avoids the destruction of flavonoids by high temperature and ensures the yield of flavonoids.

[0024] 3) In the preparation method, the extracting solution for ultrasonic extraction adopts an alcohol solution, and the purity of the flavonoid compounds in the mother liquor is higher, which reduces the difficulty of subsequent purification of the flavonoid compounds.

[0025] It is to be understood that the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the invention. BRIEF DESCRIPTION OF THE DRAWINGS

[0026] The above and other objects, features and advantages of the present invention will become more apparent through a more detailed description of exemplary embodiments of the present invention in conjunction with the accompanying drawings, wherein like reference numerals generally represent like components throughout the exemplary embodiments of the present invention.

[0027] Figure 1 is the HPLC liquid chromatogram of the mother liquor of the extract in Example 1 of the present invention;

[0028] Figure 2 is the HPLC liquid chromatogram of the golden oak extract product in Example 1 of the present invention;

[0029] Figure 3 This is the LC-MS analysis spectrum of the golden barrel cactus extract product in Example 1 of the present invention, and the liquid phase retention time is 23.104min;

[0030] Figure 4 This is the HDMS negative ion mode mass spectrum of the golden echinops extract product in Example 1 of the present invention;

[0031] Figure 5 This is the HDMS positive ion mode mass spectrum of the golden echinops extract product in Example 1 of the present invention;

[0032] Figure 6 This is the HNMR analysis spectrum of the golden quinquercus extract product in Example 1 of the present invention;

[0033] Figure 7 is the HPLC liquid chromatogram of the mother liquor of the extract in Comparative Example 1 of the present invention;

[0034] Figure 8 This is a physical picture of the antibacterial effect of the golden barrel cactus extract product in Example 1 of the present invention on Staphylococcus epidermidis and Malassezia. DETAILED DESCRIPTION

[0035] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0036] The terms used in the present invention are only for the purpose of describing specific embodiments and are not intended to limit the present invention. The singular forms "a", "the" and "the" used in the present invention and the appended claims are also intended to include plural forms unless the context clearly indicates other meanings. It should also be understood that the term "and / or" used herein refers to and includes any or all possible combinations of one or more associated listed items.

[0037] It should be understood that although the terms "first", "second", "third", etc. may be used to describe various information in the present invention, such information should not be limited to these terms. These terms are only used to distinguish the same type of information from each other. For example, without departing from the scope of the present invention, the first information may also be referred to as the second information, and similarly, the second information may also be referred to as the first information. Thus, the features defined as "first" and "second" may explicitly or implicitly include one or more of the features. In the description of the present invention, the meaning of "multiple" is two or more, unless otherwise clearly and specifically defined.

[0038] The inventors of the present application consider that the main reasons why the existing cactus extracts have no obvious antibacterial effect are: on the one hand, the effective ingredients in the extracts that have the antibacterial effect are not clearly identified; on the other hand, the antibacterial effective ingredients are destroyed during the extraction process, resulting in poor antibacterial effect.

[0039] Therefore, the inventors of the present application first obtained an extract by a traditional extraction method, and then analyzed the main components of the extract, preliminarily determined that the component was a flavonoid compound, and determined its molecular weight range (no more than 400). Based on the analysis results, the inventors of the present application further considered using a method with relatively mild temperature conditions and relatively short time to prevent the flavonoid compound from being destroyed during extraction and improve the yield. Based on this, ultrasonic extraction is first used, which helps to improve the extraction efficiency, but the inventors of the present application have found through research that when ultrasonic extraction is performed on Golden Bark Cactus, the extraction system is very viscous. The viscosity of the extraction system causes the following problems in ultrasonic extraction:

[0040] 1) The propagation of ultrasound is hindered, and the contact area between ultrasound and the extract is reduced, thereby reducing the extraction efficiency.

[0041] 2) The flavonoid components are unevenly distributed in the viscous system, resulting in the extraction effect in some areas being inferior to that in other areas, affecting the consistency and repeatability of the extraction.

[0042] 3) The heat generated during the ultrasonic process is difficult to dissipate in time due to the obstruction of the viscous system. Excessive heat accumulates in the extraction system, causing the flavonoids to decompose due to heat.

[0043] The inventors of the present application have further discovered that the problem of the too viscous extraction system in ultrasonic extraction can be solved by freeze-drying the golden equisetum cactus before ultrasonic extraction. In addition, the freeze-drying process has a low temperature and will not damage the flavonoid components.

[0044] To this end, the present application considers using a method combining freeze-drying and ultrasonic extraction to extract the golden barrel cactus, and separating and purifying the extract to obtain flavonoid compounds with better antibacterial effects.

[0045] The present invention provides a method for preparing a flavonoid compound, which comprises the following steps:

[0046] The thorns of the golden ebony cactus are removed, freeze-dried, and then ground to obtain golden ebony cactus powder;

[0047] The powder of golden equisetum cactus is subjected to ultrasonic alcohol extraction and organic membrane filtration in sequence to obtain an extract mother liquor;

[0048] The mother liquor is separated and purified to obtain the flavonoid compound represented by formula I:

[0049]

[0050] In the above preparation method, the golden hogweed cactus is first dethorned to facilitate subsequent operations. The golden hogweed cactus after dethorning is then freeze-dried. Freeze-drying can remove moisture from the cactus and increase the concentration of the extract. At the same time, the treatment is carried out in a low temperature environment, so the flavonoids can be retained to the greatest extent to prevent their loss during the water removal process. More importantly, when the freeze-dried golden hogweed cactus is subjected to ultrasonic extraction, the viscosity of the extraction system is greatly reduced, which is conducive to improving the efficiency and uniformity of the subsequent ultrasonic extraction; it can also reduce the damage to the flavonoids and reduce the difficulty of subsequent purification.

[0051] In this step, the freeze-drying temperature is preferably -40°C to -20°C, and the time is 42h to 72h. Most preferably, the freeze-drying temperature is -30°C and the time is 48h. Before freeze-drying, slicing the cactus to increase the surface area is helpful to improve the efficiency of freeze-drying, but the flavonoids are well soluble in water and are easily lost with water during the cutting process. Therefore, in this application, it is preferred to freeze-dry the whole golden equisetum cactus after thorn removal. Grind the freeze-dried cactus to obtain golden equisetum ground into powder, thereby increasing the contact area between the sample and the extract and improving the efficiency of subsequent ultrasonic extraction.

[0052] Ultrasonic extraction can be performed after obtaining the golden ebony cactus powder. For the extract, this embodiment chooses to use an alcohol solution. Compared with water extraction, the purity of flavonoids in the mother liquor obtained by alcohol extraction is higher. Furthermore, the extract of ultrasonic alcohol extraction is an ethanol solution with a concentration of 80%, and the solid-liquid ratio of golden ebony cactus powder to ethanol solution is preferably 1g: (25-45) mL, and most preferably 1g: 30ml. The temperature of ultrasonic alcohol extraction is preferably 45°C to 55°C, and the time is preferably 1.5h to 3.0h. Most preferably, the ultrasonic temperature is 55°C and the time is 2.5h. This condition is conducive to improving the yield of the mother liquor.

[0053] The mixture after ultrasonic extraction is filtered using an organic membrane to remove solid particles, as well as proteins, polysaccharides and other high molecular weight substances, thereby improving the purity of flavonoid compounds. The pore size of the organic membrane is preferably 0.45 μm, which is conducive to retaining flavonoid compounds to the greatest extent while filtering out impurities and interfering compounds. After organic membrane filtration, a mother liquor containing flavonoid compounds can be obtained.

[0054] The main components of the mother liquor were characterized, and it was determined that the main components were flavonoid compounds with the structure of Formula I.

[0055] The specific characterization method can be:

[0056] HPLC analysis of the mother liquor determined that the main chromatographic peaks were around 23.1 min;

[0057] The mother liquor was subjected to LC-MS analysis, and further analysis determined that the molecular weight of the compound corresponding to the chromatographic peak at 23.1 min should be approximately 300.3;

[0058] The mother liquor was analyzed by HDMS, and combined with the mass spectrometry data, its molecular formula was inferred to be C 16 H 12 O6.

[0059] The mother liquor was subjected to HNMR analysis, and the chemical structure of the compound was finally determined to be as shown in Formula I.

[0060]

[0061] The mother liquor is separated and purified, and the purification operation is preferably as follows:

[0062] The mother liquor is filtered; silica gel is added to the filtrate, and then it is concentrated under reduced pressure to obtain a stationary phase; the stationary phase is gradient eluted with dichloromethane and methanol as developing agents, and the elution phase with a gradient of dichloromethane: methanol = 15: 1 to dichloromethane: methanol = 5: 1 is collected to obtain a crude product; the crude product is concentrated under reduced pressure to obtain the flavonoid compound shown in the above formula I. In the above purification process, the first vacuum concentration is used to remove the solvent ethanol to obtain a solid precipitate; the second vacuum concentration is used to remove the eluent from the solution obtained after chromatographic separation to obtain a pure flavonoid compound product. The temperature of the vacuum concentration is preferably 45°C to 55°C to avoid the damage that high temperature may cause to the flavonoid compound. As a preferred embodiment of this embodiment, the mass ratio of the above mother liquor to silica gel is preferably (10-18): 1; the gradient elution range of the developing agent is preferably dichloromethane: methanol = 100: 1 to dichloromethane: methanol = 1: 1.

[0063] The purified product was subjected to HPLC, LC-MS, HDMS and HNMR analysis to confirm that it was successfully separated from the mother liquor and its structure was the compound shown in the above formula I.

[0064] Another embodiment of the present invention further provides a flavonoid compound having a molecular formula of C 16 H 12 O6, the structure is shown in formula I:

[0065]

[0066] The flavonoid compound can be prepared according to the above method. The specific embodiment is the same as the above embodiment, and will not be described in detail in this embodiment.

[0067] From the above content, it can be seen that the flavonoid compounds and preparation methods thereof provided by the embodiments of the present invention have the following advantages:

[0068] 1) It is clarified that the structure of the antibacterial active ingredient in the golden equisetum cactus extract is a flavonoid compound as described in formula I, and a corresponding preparation method of the flavonoid compound is provided, thereby improving the biological activity and application value of the extract, ensuring the consistency and repeatability of the extract, and providing a highly efficient and stable natural active substance for the antibacterial field.

[0069] 2) The preparation method first performs freeze drying before ultrasonic extraction on the thornless golden barrel cactus, which reduces the viscosity of the extraction system, makes the extraction process more uniform, and improves the consistency and repeatability of the extraction; in addition, the freeze drying process is carried out at a low temperature, which avoids the destruction of flavonoids by high temperature and ensures the yield of flavonoids.

[0070] 3) In the preparation method, the extracting solution for ultrasonic extraction adopts an alcohol solution, and the purity of the flavonoid compounds in the mother liquor is higher, which reduces the difficulty of subsequent purification of the flavonoid compounds.

[0071] Another embodiment of the present invention further provides an application of the flavonoid compound in an antibacterial product, wherein the antibacterial product comprises one or more of cosmetics, medicines, health products and food additives.

[0072] The technical solution of the present invention is further described below in conjunction with specific embodiments:

[0073] Example 1

[0074] 1. Take a golden barrel cactus, remove the thorns, and freeze-dry the golden barrel cactus as a whole. The freeze-drying temperature is -30°C and the time is 48 hours.

[0075] 2. After freeze-drying, grind in a mortar to obtain golden barrel cactus powder.

[0076] 3. Take 2 g of golden equisetum cactus powder, add 60 ml of 80% ethanol water (volume ratio), extract by ultrasonic at 55°C for 2.5 hours, and then filter with a 0.45 μm organic membrane to obtain 50.87 g of extract mother liquor.

[0077] 4. Separation and purification: Add 4.5 g of silica gel to 50.78 g of the filtered ethanol solution, and concentrate under reduced pressure at a concentration temperature of 50°C to obtain a solid, and perform normal phase separation. The developing solvent gradient used is dichloromethane: methanol = 100: 1 to dichloromethane: methanol = 1: 1, and the product gradient is dichloromethane: methanol = 15: 1 to dichloromethane: methanol = 5: 1. The obtained product is concentrated under reduced pressure at a concentration temperature of 50°C to obtain 0.81 g of the product.

[0078] [Qualitative analysis]

[0079] The mother liquor obtained in step 3 and the product obtained in step 4 were subjected to HPLC analysis, and the HPLC analysis conditions were as follows:

[0080] Analysis equipment: Hitachi full wavelength liquid phase analysis system

[0081] Mobile phase: A-0.2% formic acid in water, B-methanol

[0082] Chromatographic column: C18, 5μm, 4.6*150mm

[0083] Detection conditions: detection wavelength 360nm, column temperature 40℃, injection volume 20μl, flow rate 1.2ml / min

[0084] The mobile phase gradient conditions are shown in Table 1:

[0085] Table 1 Mobile phase gradient conditions

[0086] Time (min) 0 10 20 25 A% 70 55 45 30 B% 30 45 55 70

[0087] The HPLC liquid chromatograms of the extract mother solution and the golden oak extract product are shown in 1 and Figure 2 The liquid phase analysis results are shown in Table 2:

[0088] Table 2 HPLC analysis results

[0089]

[0090] Depend on Figure 1-2 As shown in Table 2, the purity of the extract mother liquor is 43.18%, and the purity of the golden barrel cactus extract product reaches 99.75% after normal phase purification, thus achieving the effect of product purification.

[0091] Through HPLC analysis, it can be found that the main chromatographic peak of the mother solution is around 23.1min. The product is further studied by LC-MS on the chromatographic peak molecular weight of the peak.

[0092] LC-MS analysis conditions are as follows:

[0093] Analytical equipment: Waters mass spectrometer

[0094] Mobile phase: same as HPLC

[0095] Chromatographic column: same as HPLC

[0096] Detection conditions: Same as HPLC

[0097] Mobile phase gradient conditions were the same as those of HPLC

[0098] The LC-MS analysis spectrum of the product is as follows Figure 3 As shown in the figure, it can be seen that the molecular weight of the compound corresponding to the chromatographic peak at 23.1min should be about 300.3.

[0099] The golden equisetum extract product was further analyzed by high-resolution mass spectrometry (HDMS). The injection volume was increased by the analytical liquid phase system, and the chromatographic peak with a retention time of 23 minutes was manually collected for further high-resolution mass spectrometry analysis to infer the possible molecular formula. The negative ion mode mass spectrum and the positive ion mode mass spectrum were Figure 4 and Figure 5 As shown,

[0100] The mass spectrometer in negative ion mode of high-resolution mass spectrometry showed that the molecular ion peak of M-1 had an accurate molecular weight of 299.0551, and the molecular ion peak of M+1 had an accurate molecular weight of 301.0707. Based on the structural characteristics of flavonoids, the elemental composition was limited to CHO, and the most likely molecular formula was inferred to be C 16 H12 O6.

[0101] The golden quince extract product was subjected to nuclear magnetic hydrogen spectrum (HNMR) analysis. The HNMR analysis spectrum is shown in Figure 6 shown.

[0102] Through the combination of HNMR and HDMS, it can be seen that the deviation between the measured values ​​of positive and negative ions and the theoretical values ​​is much less than 10ppm, and the matching degree is very high. It is determined that the structural formula is as shown in I:

[0103]

[0104] Example 2

[0105] The only difference from Example 1 is:

[0106] In step 3, the ultrasonic temperature was 45° C. and the ultrasonic time was 2.5 hours to obtain 50.11 g of extract mother liquor.

[0107] Example 3

[0108] The only difference from Example 1 is:

[0109] In step 3, the ultrasonic temperature was 55° C. and the ultrasonic time was 1.5 hours to obtain 50.03 g of extract mother liquor.

[0110] It can be seen from Examples 1 to 3 that when the ultrasonic alcohol extraction temperature is 55° C. and the time is 2.5 h, the yield of the mother liquor is the highest, which correspondingly indicates that the yield of flavonoids is the highest.

[0111] Comparative Example 1

[0112] The only difference from Example 1 is:

[0113] The extract in step 3 is 60 ml of water, and 60.78 g of extract mother liquor is obtained.

[0114] The mother liquor of the extract of Comparative Example 1 was subjected to HPLC respectively. The HPLC spectra are shown in Figure 7 The analysis results are shown in Table 3. Figure 1 and Figure 7 As shown in Tables 2 and 3, the purity of flavonoid compounds in the mother liquor of the extract obtained by alcohol extraction is higher.

[0115] Table 3 HPLC analysis results

[0116]

[0117]

[0118]

Inhibitory experiment

[0119] (I) Experimental steps

[0120] 1. Sample preparation: Weigh 3 portions of the extract of Aquilegia chinensis prepared in Example 1 in an ultra-clean workbench, 3 g each; add 1000 g, 200 g, and 100 g of sterile water, respectively, vortex for 1 minute, place the centrifuge tube in an ultrasonic clarifying instrument for ultrasonic dissolution, centrifuge at 4500 rpm for 30 minutes, take the centrifugal supernatant and filter it aseptically through a 0.22 micron disposable needle-type sterile filter. The sample is the sample to be tested. The information of the sample to be tested is listed in Table 4. The sample to be tested is stored at 4°C.

[0121] Table 4 Information of samples to be tested

[0122] Serial number sample concentration 1 Sterile water (negative control) / 2 Ampicillin (positive control) 280mM 3 Golden Echinops Extract 10mM 4 Golden Echinops Extract 50mM 5 Golden Echinops Extract 100mM

[0123] 2. Preparation of indicator bacteria suspension

[0124] Activation of bacterial strains: The test strains (Staphylococcus epidermidis and Malassezia) were inoculated with LB medium and modified Martin medium the day before, with an inoculation ratio of 1:1000. Staphylococcus epidermidis and Malassezia were cultured at 36°C±1°C and 150 rpm for 18-24 hours.

[0125] Preparation of bacterial suspension: Measure the absorbance of activated bacterial solution at 600nm, dilute with LB medium and modified Martin medium to OD600 of about 0.6±0.05 (i.e., bacterial suspension concentration is 10 8 CFU / mL)

[0126] Preparation of test plates: Heat the prepared NA medium and modified Martin agar medium to dissolve, cool to 55-60°C (can be kept warm in a water bath), add the prepared indicator bacteria suspension at a rate of 0.1% to the medium, mix thoroughly, pour into a sterilized plate, gently shake the plate to make it evenly flat, and wait for it to solidify before use.

[0127] 3. Determination

[0128] Sample determination: Use a 1 mL sterile pipette tip to make 5 holes in the test plate containing the indicator bacteria, measure 100 μL of the sample, and slowly add it to the holes. Place the plate cultured with Staphylococcus epidermidis and Malassezia in a 36°C ± 1°C constant temperature incubator, incubate upright until the inhibition zone is clear, and measure the diameter of the inhibition zone with a caliper.

[0129] Control determination: Take sterile water as blank control and 100 mg / mL ampicillin as positive control.

[0130] (II) Experimental results

[0131] The antibacterial effect of the golden oak extract product prepared in Example 1 on Staphylococcus epidermidis and Malassezia is shown in the figure below: Figure 8 As shown, Figure 8 "A + " indicates ampicillin (positive control), "A + " " indicates, "H2O" indicates sterile water (negative control), "10" indicates golden equisetum extract (10mM), "50" indicates golden equisetum extract (50mM), and "100" indicates golden equisetum extract (100mM). The antibacterial effect data are shown in Tables 5 and 6, respectively.

[0132] Table 5 Antibacterial effect of golden quince extract products on Staphylococcus epidermidis

[0133] Serial number sample Diameter of inhibition zone (mm) 1 Sterile water (negative control) / 2 Ampicillin (positive control) 15.4 3 Echinops chinensis extract (10mM) 9.8 4 Echinops chinensis extract (50mM) 12.4 5 Echinops chinensis extract (100mM) 13.7

[0134] Table 6 Antibacterial effect of golden quinquercetin extract products on Malassezia

[0135] Serial number sample Diameter of inhibition zone (mm) 1 Sterile water (negative control) / 2 Ampicillin (positive control) 11.5 3 Echinops chinensis extract (10mM) 8.3 4 Echinops chinensis extract (50mM) 11.6 5 Echinops chinensis extract (100mM) 12.5

[0136] The results of the antibacterial experiment show that the purified golden barrel champaca extract (i.e., the flavonoid compound shown in the above formula I) has a good antibacterial effect; and as the concentration of the golden barrel champaca extract increases, the antibacterial effect also increases.

[0137] The embodiments of the present invention have been described above, and the above description is exemplary, not exhaustive, and is not limited to the disclosed embodiments. Many modifications and changes will be apparent to those of ordinary skill in the art without departing from the scope and spirit of the described embodiments. The selection of terms used herein is intended to best explain the principles of the embodiments, practical applications, or improvements to the technology in the market, or to enable other persons of ordinary skill in the art to understand the embodiments disclosed herein.

Claims

1. A method for preparing flavonoid compounds, characterized in that: include: The thorns of the golden ebony cactus are removed, freeze-dried, and then ground to obtain golden ebony cactus powder; The powder of golden ebony cactus is subjected to ultrasonic alcohol extraction and organic membrane filtration in sequence to obtain an extract mother liquor; The mother liquor is separated and purified to obtain the flavonoid compound represented by formula I:

2. The preparation method according to claim 1, characterized in that: The freeze-drying temperature is -40°C to -20°C, and the time is 42h to 72h.

3. The preparation method according to claim 1, characterized in that: The temperature of the ultrasonic alcohol extraction is 45° C. to 55° C., and the time is 1.5 h to 3.0 h.

4. The preparation method according to claim 1, characterized in that: The ultrasonic alcohol extraction extract is an ethanol solution with a concentration of 80%, and the solid-liquid ratio of the golden ebony cactus powder to the ethanol solution is 1g: (25-45)mL.

5. The preparation method according to claim 1, characterized in that: The pore size of the organic membrane is 0.45 μm.

6. The preparation method according to claim 1, characterized in that: The separation and purification specifically comprises: filtering the mother liquor; adding silica gel to the filtrate, and then concentrating under reduced pressure to obtain a stationary phase; gradient eluting the stationary phase with dichloromethane and methanol as developing agents, collecting the elution phase with a gradient of dichloromethane:methanol=15:1 to dichloromethane:methanol=5:1 to obtain a crude product; and concentrating the crude product under reduced pressure to obtain the flavonoid compound shown in formula I.

7. The preparation method according to claim 7, characterized in that: The temperature of the reduced pressure concentration is 45°C to 55°C.

8. The preparation method according to claim 7, characterized in that: The mass ratio of the mother liquor to the silica gel is (10-18):1; the gradient elution range of the developing agent is dichloromethane:methanol=100:1 to dichloromethane:methanol=1:

1.

9. A flavonoid compound, characterized in that: Its structure is shown in Formula I:

10. Use of the flavonoid compounds as claimed in claim 9 in antibacterial products, wherein the antibacterial products include one or more of cosmetics, medicines, health products and food additives.

Citation Information

Patent Citations

  • Preparation method of neoflavone from natural plant

    CN102584806A

  • Preparation method for extracting total flavone from cactus

    CN110538211A

  • Application of natural flavonoid compounds as antibacterial agent in inhibition of human pathogenic bacteria

    CN113368102A

  • Application of natural source flavonoid compounds as antibacterial agents in inhibition of plant pathogenic bacteria

    CN113455507A

  • New pharmaceutical of cactus total flavone and its preparation method

    CN1442146A

Cited By

  • Flavonoid compound, and preparation method therefor and use thereof

    WO2026037421A1